Acadia Pharma's psychosis drug proven better than placebo in dementia patients
December 04, 2019 at 20:45 PM EST
Acadia Pharmaceuticals Inc said on Wednesday dementia patients taking its drug Nuplazid were nearly three times less prone to a psychotic relapse than those on placebo.